OACCW Oaktree Acquisition Corp. III Life Sciences - Warrant
$0.82
Price · Aug 6, 2026
Fundamentals as of Aug 12, 2026
52W Range
$1–$1
22% of range
Analyst Rating
—
Price Target
—
P/E (TTM)
—
ROE
-109.5%
Net Profit Margin
—
OACCW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.82
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
-109.5%
Debt/Equity
-0.0
52W Range
$1 – $1
OACCW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
OACCW
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
OACCW
Peer Median
ROA
3.7%
—
ROE
-109.5%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
OACCW
Peer Median
Debt / Equity
-0.0
—
Current Ratio
1.2
—
Quick Ratio
1.1
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
OACCW
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
OACCW
Peer Median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 5
| Metric | Trend | 2025 |
|---|---|---|
| Operating Income | $-1M | |
| Interest Income | $8M | |
| Other Non-op | $8M | |
| Net Income | $7M | |
| EBITDA | $-1M |
Balance Sheet 13
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $1M | |
| Prepaid Expense | $113.3K | |
| Current Assets | $2M | |
| Total Assets | $203M | |
| Accounts Payable | $502.0K | |
| Short-term Debt | $11.8K | |
| Current Liabilities | $1M | |
| Total Liabilities | $8M | |
| Total Debt | $11.8K | |
| Paid-in Capital | $0 | |
| Retained Earnings | $-7M | |
| Stockholders' Equity | $-7M | |
| Liabilities + Equity | $203M |
Cash Flow 3
| Metric | Trend | 2025 |
|---|---|---|
| Operating Cash Flow | $-422.1K | |
| Investing Cash Flow | $500.0K | |
| Financing Cash Flow | $0 |
Profitability 2
| Metric | Trend | 2025 |
|---|---|---|
| ROA | 3.7% | |
| ROE | -109.5% |
Liquidity & Solvency 3
| Metric | Trend | 2025 |
|---|---|---|
| Current Ratio | 1.2 | |
| Quick Ratio | 1.1 | |
| Debt / Equity | -0.0 |
Valuation (TTM) 1
| Metric | Trend | 2025 |
|---|---|---|
| Net Income TTM | $7M |
Income Statement 5
| Metric | Trend | Q2 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating Income | $-262.0K | $-225.6K | $-269.8K | $-444.8K | |
| Interest Income | $2M | $2M | $2M | $2M | |
| Other Non-op | $2M | $2M | $2M | · | |
| Net Income | $2M | $2M | $2M | $2M | |
| EBITDA | $-262.0K | $-225.6K | $-269.8K | $-444.8K |
Balance Sheet 13
| Metric | Trend | Q2 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $1M | $1M | $1M | |
| Prepaid Expense | $80.3K | $152.0K | $175.8K | $201.0K | |
| Current Assets | $1M | $1M | $2M | $1M | |
| Total Assets | $207M | $201M | $199M | $197M | |
| Accounts Payable | $782.2K | $414.1K | $381.6K | $395.7K | |
| Short-term Debt | $11.8K | $11.8K | $11.8K | $11.8K | |
| Current Liabilities | $2M | $1M | $1M | $1M | |
| Total Liabilities | $9M | $8M | $8M | $8M | |
| Total Debt | $11.8K | $11.8K | $11.8K | $11.8K | |
| Paid-in Capital | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-7M | $-7M | $-7M | $-7M | |
| Stockholders' Equity | $-7M | $-7M | $-7M | $-7M | |
| Liabilities + Equity | $207M | $201M | $199M | $197M |
Cash Flow 2
| Metric | Trend | Q2 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-97.3K | $-56.5K | $-146.1K | $-75.6K | |
| Investing Cash Flow | · | $0 | · | · |
Profitability 2
| Metric | Trend | Q2 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| ROA | 0.79% | 1.9% | 1.9% | 1.7% | |
| ROE | -22.9% | -58.1% | -57.3% | -50.9% |
Liquidity & Solvency 3
| Metric | Trend | Q2 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | 0.7 | 1.2 | 1.4 | 1.4 | |
| Quick Ratio | 0.7 | 1.1 | 1.2 | 1.2 | |
| Debt / Equity | -0.0 | -0.0 | -0.0 | -0.0 |
Valuation (TTM) 1
| Metric | Trend | Q2 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Net Income TTM | $7M | $5M | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Net Income | $7M | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Debt / Equity | -0.0 | — |
| Current Ratio | 1.2 | — |
| Quick Ratio | 1.1 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 31 filers · $2.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 4 (+3 vs prior Q) | 1 (-3 vs prior Q) | 4 (+2 vs prior Q) | 4 (+1 vs prior Q) | +26K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $323,000 | 340,000 | 12.06% | Shares |
| AQR Arbitrage LLC | $251,087 | 282,120 | 9.38% | Shares |
| TORONTO DOMINION BANK | $178,617 | 189,816 | 6.67% | Shares |
| Walleye Capital LLC | $159,569 | 169,502 | 5.96% | Shares |
| Decagon Asset Management LLP | $153,168 | 162,702 | 5.72% | Shares |
| Weiss Asset Management LP | $137,529 | 144,767 | 5.14% | Shares |
| JPMORGAN CHASE & CO | $129,050 | 145,000 | 4.82% | Shares |
| Linden Advisors LP | $126,600 | 120,000 | 4.73% | Shares |
| Boussard & Gavaudan Investment Management LLP | $112,500 | 150,000 | 4.20% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $99,701 | 105,907 | 3.72% | Shares |
| MOORE CAPITAL MANAGEMENT, LP | $98,847 | 105,000 | 3.69% | Shares |
| Shaolin Capital Management LLC | $94,728 | 100,625 | 3.54% | Shares |
| Alberta Investment Management Corp | $94,140 | 100,000 | 3.52% | Shares |
| LMR Partners LLP | $89,433 | 95,000 | 3.34% | Shares |
| Periscope Capital Inc. | $84,726 | 90,000 | 3.16% | Shares |
| GRITSTONE ASSET MANAGEMENT LLC | $74,353 | 78,981 | 2.78% | Shares |
| Lineage Point Capital LP | $74,303 | 78,928 | 2.77% | Shares |
| ExodusPoint Capital Management, LP | $56,484 | 60,000 | 2.11% | Shares |
| TENOR CAPITAL MANAGEMENT Co., L.P. | $56,484 | 60,000 | 2.11% | Shares |
| WHITEBOX ADVISORS LLC | $47,070 | 50,000 | 1.76% | Shares |
| Sculptor Capital LP | $47,070 | 50,000 | 1.76% | Shares |
| DLD Asset Management, LP | $41,910 | 44,519 | 1.56% | Shares |
| K2 PRINCIPAL FUND, L.P. | $37,947 | 40,369 | 1.42% | Shares |
| MILLENNIUM MANAGEMENT LLC | $32,949 | 35,000 | 1.23% | Call option |
| Verition Fund Management LLC | $22,601 | 23,790 | 0.84% | Shares |
| Schonfeld Strategic Advisors LLC | $15,533 | 16,500 | 0.58% | Shares |
| PICTON MAHONEY ASSET MANAGEMENT | $14,121 | 15,000 | 0.53% | Shares |
| Clear Street Group Inc. | $8,731 | 9,274 | 0.33% | Shares |
| CLEAR STREET LLC | $7,767 | 8,876 | 0.29% | Shares |
| CITIGROUP INC | $7,600 | 8,000 | 0.28% | Call option |
| UBS Group AG | $528 | 561 | 0.02% | Shares |